Since it was first synthesized by Stetter and Mayer in the 1960s, 1,4,7,10-tetraazacyclododecane and its derivatives have stimulated continued interest from generations of investigators due to the strong coordination ability with respect to metal cations, including transition metal ions and lanthanide ions[1–3]. The associated metal complexes exhibit enhanced thermodynamic stability and kinetic inertness. 1,4,7,10-tetraazacyclododecane and its derivatives are widely used in medicine[4,5], enzyme modeling[6], as non-viral gene delivery vectors[7], and in metal cation extraction[8].
In the synthesis of symmetric di- or tetra- substituted 1,4,7,10-tetraazacyclododecane derivatives, 1,7-dibenzyl-1,4,7,10-tetraazacyclododecane plays an important role as the benzyl group is readily removed by catalytic hydrogenolysis[9–11]. Catalytic hydrogenolysis of the benzyl group after reaction of 1,7-dibenzyl-1,4,7,10-tetraazacyclododecane with tert butyl bromoacetate produces the essential ligand, DO2A-t-Bu ester[12].
Currently, there are four main synthetic routes to 1,7-dibenzyl-1,4,7,10-tetraazacyclododecane.
Synthetic route 1: The protective bridged macrocyclic 1,4,7,10-tetraazacyclododecane is first generated by reacting 1,4,7,10-tetraazacyclododecane with glyoxal (40% wt. %) in methanol at an equimolar ratio, then reacted with excess benzyl bromide in acetonitrile at room temperature for 96 h. A subsequent increase of temperature to 45℃ for 72 h generates 1,7-dibenzyl substituted bridged macrocyclic 1,4,7,10-tetraazacyclododecane, which is deprotected with hydrazine hydrate[13] or 3M solution NaOH[14] or an ethanol solution of hydroxylamine [15], to obtain 1,7-dibenzyl-1,4,7,10-tetraazacyclododecane with high yields. However, the process is lengthy (> 240h) and hydrazine hydrate is highly toxic. Fatima Oukhatar has exploited the transamination of o-diamines in the deprotection process, rendering the deprotection step safer and more efficient[16].
Synthetic route 2: The reaction of 1,4,7,10-tetraazacyclododecane with benzyloxyformyl chloride (cbzcl) generates1,7-dibenzyloxycarbonyl protected 1,4,7,10-tetraazacyclododecane, which reacts with benzyl bromide in acetonitrile, and debenzyloxycarbonyl using 4M HBr in acetic acid to obtain tetrahydrobromide from 1,7-dibenzyl-1,4,7,10-tetraazacyclododecane [17]. This method suffers from such disadvantages as lower yield, the requirement for separation by column chromatography, and the formation of hydrobromide.
Synthetic route 3: 1,4,7,10-tetraazacyclododecane reacts with benzaldehyde to generate imine, and then undergoes NaBH(OAC)3 reduction to generate 1,7-dibenzyl-1,4,7,10-tetraazacyclododecane. This method delivers low yields[18].
Synthetic route 4: The Cyclization of diethylenetriamine with diethyl 3,3'- iminodipropionate (reaction time 7 days, 32% yield) affords 1,4,7,10-tetraazacycle-2,6-dione (1,4,7,10-tetraazacyclodecane-2,6-dione), followed by reaction with benzaldehyde generates imines. Subsequent reduction using NaBH(OAC)3 affords 1,7-dibenzyl-1,4,7,10-tetraazacycle-2,6-dione, and additional reduction using diisobutyl aluminum hydride affords 1,7-dibenzyl-1,4,7,10-tetraazacyclododecane [19–21]. This reaction is time-consuming and tedious operation, delivers low yields, and requires hazardous reducing agents.
Taking an overview, the laboratory synthesis of 1,7-dibenzyl1,4,7,10-tetraazacyclododecane requires many, time-consuming, steps and delivers low yields, limiting practical applications.
In a series of experiments to catalyze the hydrogenolysis of 1,4,7,10-tetrabenzyl-1,4,7,10-tetraazacyclododecane using the 10% Pd/C and ammonium formate system, we have observed the selective hydrogenolysis of two benzyl groups (in the para position), which afforded 1,7-dibenzyl-1,4,7,10-tetraazacyclododecane in high yields, under mild experimental conditions in a more efficient (less time-consuming) process.
This method facilitates convenient and efficient synthesis of 1,7-dibenzyl-1,4,7,10-tetraazacyclododecane, and can serve as a general approach for the synthesis of 1,7-diaryl compounds.